Shares of Oxford Industries, Inc. (NYSE:OXM – Get Free Report) have earned an average recommendation of “Reduce” from the four research firms that are covering the firm, Ratings reports. One research ...

If you’re looking for things to collect for future investment now is a great time. Items to collect for future investments.

"Slim Aarons: Gold Coast," an exhibition that highlights Aarons' years of work in Palm Beach and how that work intertwined with Palm Beach icon Lilly Pulitzer, kicks off the Ann Norton Sculpture ...

Analyst David Risinger of Leerink Partners reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), retaining the price target of $970.00. Don't Miss our Black Friday Offers: David Risinger ...

https://www.tipranks.com/news/company-announcements/mineralys-therapeutics-announces-q3-2024-results-and-updates Deutsche Bank analyst James Shin lowered the firm’s ...

Deutsche Bank lowered the firm’s price target on Eli Lilly (LLY) to $1,015 from $1,025 and keeps a Buy rating on the shares following the ...

Several research analysts have recently commented on the stock. Barclays increased their price target on shares of Eli Lilly and Company from $913.00 to $1,025.00 and gave the stock an ...

Deutsche Bank analyst James Shin lowered the firm’s price target on Eli Lilly (LLY) to $1,015 from $1,025 and keeps a Buy rating on the shares. Following the Q3 earnings report, it wouldn’t be ...

Citi raised the firm’s price target on Eli Lilly (LLY) to $1,250 from $1,060 and keeps a Buy rating on the shares following a transfer of analyst coverage. GLP-1 adoption has fueled Lilly’s ...

“UNC13A is a highly compelling genetic target directly linked to ALS disease ... have spied potential in restoring UNC13A. In June, Lilly paid QurAlis $45 million for a preclinical splice ...